📰 Psychedelics News
Curated updates on microdosing, research, policy, and community.
Filters
MAPS Sends Expert Delegation to United Nations Commission on Narcotic Drugs
Vienna, Austria; March 9, 2026 —The Multidisciplinary Association for Psychedelic Studies (MAPS) will send senior academics, advocates, Veterans, and policy experts to the 69th session of the United Nations Commission...
Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects the Plant’s Roots
HB26-1325 would create a state-supported ibogaine research program to study addiction and PTSD treatment, including for veterans. One provision stands out: a requirement that participating organizations create benefit...
Will the FDA ever fast-track psychedelic drugs? 5 Questions with drug regulation expert Daniel Eisenkraft Klein
Eisenkraft Klein discusses the FDA’s new accelerated drug review program.
Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape
Jen Davenport joins Psychedelics Today to interview the CEO and co-founder Joe Moore about the growth of Psychedelics Today, the broader psychedelic ecosystem, and how professionals are beginning to engage with psyche...
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
AtaiBeckley is in structured discussions with pharma companies and royalty investors about a potential partnership for its lead candidate, intranasal 5-MeO-DMT (BPL-003) for treatment-resistant depression (TRD), sourc...
Psilocybin Isn’t Legal Yet. So, Why Are States Writing Laws for It?
PLUS ketamine spoons, sleep tripping, and psilocybin vs. anti-depressants. [...] Read More... The post Psilocybin Isn’t Legal Yet. So, Why Are States Writing Laws for It? appeared first on DoubleBlind Mag.
The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders
Substance use disorders (SUDs) remain among the most persistent global public health challenges. Despite decades of pharmacological and behavioral innovation, relapse rates remain high, and many individuals struggle t...
A new “magic mushroom” drug could treat depression without psychedelic hallucinations
Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending side effects. Researchers created modified versions of psilocin — the active form of psilocybin from ...
The Subtle Harms of Psychedelic-Assisted Therapy and Facilitation (Part 2)
Psychedelic therapy, due to the combination of heightened suggestibility, powerful altered states, and unique power imbalances, opens the door to undue influence of the kind not seen in ordinary psychotherapy. The pos...
AtaiBeckley’s MDMA product could treat social anxiety; HHS Secretary Kennedy talks psychedelics on Rogan podcast; WV Senate and SD legislature pass Compass trigger bills
Plus: Pilot study uses psilocybin for post-treatment Lyme disease and Psychedelic-assisted therapy bill rejected then resurrected in Georgia
Pα+ February 2026 Psychedelic Bill Roundup
A state-by-state and federal review of psychedelics-related bills introduced or advanced in February 2026, including pilot programs, trigger laws, and research programs.
Global Altered States: LA’s 2C-B Economy
New Series: Global Altered States
For the Love of Tie-Dye, Plz Stop Over Hyping Psychedelic Studies
Psychedelic research is booming, but the hype is outpacing the science. [...] Read More... The post For the Love of Tie-Dye, Plz Stop Over Hyping Psychedelic Studies appeared first on DoubleBlind Mag.
Inside the Ketamine Spoon Economy at Raves
Wearing a ketamine spoon around your neck will get you further at raves than a VIP pass. [...] Read More... The post Inside the Ketamine Spoon Economy at Raves appeared first on DoubleBlind Mag.
How to Get Your Parents Curious About Taking Mushrooms
Think your parent could benefit from psilocybin? Here’s how to talk to them—straight from those who’ve done it successfully. [...] Read More... The post How to Get Your Parents Curious About Taking Mushrooms appeared ...